Active Shortage Injection Endocrinology/Metabolism
Dextrose Monohydrate 10% Inj · 1,655 days since initial FDA posting
Brand: DEXTROSE
FDA lists Dextrose Monohydrate 10% Inj as Active Shortage (B. Braun Medical Inc.).
Availability on file: Available
Dextrose Monohydrate 10% Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dextrose Monohydrate 10% Injection
- Manufacturer
- B. Braun Medical Inc.
- Dosage Form
- Injection
- Presentation
- Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20)
- Package NDC
- 0264-7520-20
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 1, 2022
- Last Updated
- Mar 19, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Dextrose Shortage Records
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection